
Keywords: inferior colliculus, neuropeptide Y, optogenetics, transgenic mouse lines
Abstract
Growing evidence suggests that neuropeptide signaling shapes auditory computations. We previously showed that neuropeptide Y (NPY) is expressed in the inferior colliculus (IC) by a population of GABAergic stellate neurons and that NPY regulates the strength of local excitatory circuits in the IC. NPY neurons were initially characterized using the NPY-hrGFP mouse, in which humanized renilla green fluorescent protein (hrGFP) expression indicates NPY expression at the time of assay, i.e., an expression-tracking approach. However, studies in other brain regions have shown that NPY expression can vary based on several factors, suggesting that the NPY-hrGFP mouse might miss NPY neurons not expressing NPY on the experiment date. Here, we hypothesized that neurons with the ability to express NPY represent a larger population of IC GABAergic neurons than previously reported. To test this hypothesis, we used a lineage-tracing approach to irreversibly tag neurons that expressed NPY at any point prior to the experiment date. We then compared the physiological and anatomical features of neurons labeled with this lineage-tracing approach to our prior data set, revealing a larger population of NPY neurons than previously found. In addition, we used optogenetics to test the local connectivity of NPY neurons and found that NPY neurons provide inhibitory synaptic input to other neurons in the ipsilateral IC. Together, our data expand the definition of NPY neurons in the IC, suggest that NPY expression might be dynamically regulated in the IC, and provide functional evidence that NPY neurons form local inhibitory circuits in the IC.
NEW & NOTEWORTHY Across brain regions, neuropeptide Y (NPY) expression is dynamic and influenced by extrinsic and intrinsic factors. We previously showed that NPY is expressed by a class of inhibitory neurons in the auditory midbrain. Here, we find that this neuron class also includes neurons that previously expressed NPY, suggesting that NPY expression is dynamically regulated in the auditory midbrain. We also provide functional evidence that NPY neurons contribute to local inhibitory circuits in the auditory midbrain.
INTRODUCTION
Neuropeptides are small molecules expressed by a large number of neurons throughout the brain and are often coreleased with classical fast neurotransmitters such as GABA and glutamate (1–3). The corelease of fast neurotransmitters and neuropeptides allows a prolonged reconfiguration of neuronal circuits since neuropeptides exhibit a slower modulatory role by activating metabotropic receptors (4–7). In addition, neuropeptides can act over longer distances from the release site, thereby shaping neuronal circuits in ways that are not possible with fast neurotransmitters alone (1, 8).
Neuropeptide Y (NPY) is a 36-amino-acid peptide that has been implicated in the modulation of feeding behavior, fear, anxiety, seizures, pain perception, stress responses, and memory (9–16). NPY has also been used as a molecular marker to identify neuron classes in several brain regions (17–19). However, because NPY expression can vary over time, there is a distinction between a cell’s ability to express NPY and a cell’s expression of NPY at the time experiments are performed. This raises interesting questions regarding whether the state of a cell should be considered when classifying a cell as an NPY neuron. For example, in the dorsal medial hypothalamus and in the arcuate nuclei, the expression of NPY changes with energy status and food restriction (13, 20–22). In the auditory brainstem, noise exposure increases the proportion of lateral olivocochlear (LOC) neurons that express NPY (23). In addition, NPY expression can change across development (16, 24–26).
Although the role of NPY in auditory processing remains unknown, NPY is expressed in at least two regions in the subcortical auditory pathway: the LOC (23) and the inferior colliculus (IC) (17). The IC forms the major part of the auditory midbrain and is essential for many auditory computations including sound localization and speech processing (27–29). In the IC, NPY neurons were identified using the NPY-hrGFP mouse line, in which humanized renilla green fluorescent protein (hrGFP) expression reports NPY expression at the time of the experiment. Using this expression-tracking approach, our group showed that NPY-expressing neurons represent a distinct class of stellate GABAergic neurons, accounting for nearly one-third of IC inhibitory neurons (17). However, because expression of NPY is dynamic and can be influenced by extrinsic factors, it is likely that an expression-tracking approach underestimated the number of neurons that should be counted as NPY neurons.
Here, we hypothesized that the NPY neuron class represents a larger population of IC GABAergic neurons than previously reported and that this expanded population remains homogeneous in its physiological and anatomical properties. To test this hypothesis, we compared two methods for labeling NPY neurons: a lineage-tracing approach and an expression-tracking approach. First, we used NPY-FlpO × Ai65F mice to irreversibly tag neurons that expressed NPY at any point prior to the experiment day, including during development. We refer here to neurons labeled through this lineage-tracing approach as NPYflp neurons. We then compared the properties of NPYflp neurons to our previous data set obtained from the NPY-hrGFP mouse line in which hrGFP expression reflects active expression of NPY. We refer to these latter neurons, which are labeled through an expression-tracking approach, as NPYgfp neurons. Our data reveal that NPYflp neurons represent a larger population of IC neurons than NPYgfp neurons due to the inclusion of neurons that were not expressing NPY at the time of experiments. Despite the larger number of NPYflp neurons, both labeling approaches identified neurons with similar physiological and morphological properties, suggesting that they are part of the same neuron class. Since most neurons in the IC have local axon collaterals (30), we next hypothesized that NPY neurons send local inhibitory projections to other IC neurons. Using optogenetic circuit mapping, we found that NPYflp neurons provide inhibitory, GABAergic inputs to other neurons in the local IC. Together, our data indicate that the NPY neuron class in the IC should be expanded to include a set of GABAergic neurons not actively expressing NPY and that NPY neurons form local inhibitory circuits in the IC. These results lay the foundation for future studies that aim to identify whether expression of NPY in the IC is dynamically regulated by intrinsic or extrinsic factors or by developmental states.
MATERIALS AND METHODS
Animals
All experiments were approved by the University of Michigan Institutional Animal Care and Use Committee and were in accordance with the National Institutes of Health’s Guide for the Care and Use of Laboratory Animals. Mice were kept on a 12-h day/night cycle with ad libitum access to food and water. To visualize NPY neurons, we used either NPY-hrGFP mice (Jackson Laboratory, Stock No. 006417) (31) in which NPYgfp neurons are identified by the expression of hrGFP or NPY-FlpO × Ai65F mice in which NPYflp neurons are identified by tdTomato expression by crossing Npy-IRES2-FlpO-D mice (Jackson Laboratory, Stock No. 030211) (32) with Ai65F mice (Jackson Laboratory, Stock No. 032864) (32). All mice were on a C57BL/6J background, and mice of both sexes were used for all experiments.
Comparison of the Distribution of NPY Neurons
To evaluate the distribution and density of fluorescent cells, 10 NPY-hrGFP mice and four NPY-FlpO × Ai65F mice were deeply anesthetized in an isoflurane drop jar and then perfused transcardially with phosphate-buffered saline (PBS) for 30–60 s followed by 10% neutral buffered formalin (Millipore Sigma, Cat. No. HT501128) for 10–15 min until ∼100 mL of formalin was perfused. Brains were collected and postfixed for 2 h, then stored in PBS with 20% sucrose until sectioning. Brains were sectioned on a freezing microtome into 40-µm-thick sections. One series (every third section) from each brain was mounted onto gelatin-coated slides, air-dried, and coverslipped with DPX mountant (Millipore Sigma, Cat. No. 317616).
Photomicrographs were obtained with a Zeiss AxioImager.Z2 fluorescence microscope and Hamamatsu Orca Flash 4.0 camera using Zeiss Zen Pro software. Low-magnification photomicrographs were collected with a ×2.5 objective lens. High-magnification photomicrographs were collected as z-stacks using a ×63 oil-immersion objective lens (numerical aperture, NA = 1.4) with optical sections collected at 0.26-µm depth intervals. Structured illumination with an Apotome 3 (Zeiss) was used to provide optical sectioning. Maximum intensity projections were created from each z-stack.
In nine NPY-hrGFP mice and three NPY-FlpO × Ai65F mice, fluorescent cells were plotted through the rostro-caudal extent of the IC using Neurolucida Software (MBF Biosciences) and a Zeiss AxioImager.Z2 fluorescence microscope with a Hamamatsu Orca Flash 4.0 camera. We plotted 24,609 cells across nine NPY-hrGFP mice and 33,911 cells across three NPY-FlpO × Ai65F mice. IC subdivisions were differentiated with separate tissue series stained for GAD67 and GlyT2 proteins [see Silveira et al. (17) for details]. Plots, counts of cells, and areas for each subdivision were exported using Neurolucida Explorer (MBF Biosciences). Plots were prepared with Adobe Illustrator and numerical analyses were performed and bar graphs were created in Microsoft Excel.
Fluorescent In Situ Hybridization
The NPY-FlpO × Ai65F mouse line was validated using an RNAscope assay for fluorescent in situ hybridization with probes targeted to tdTomato, Npy and Vgat (Slc32a1; Advanced Cell Diagnostics, Cat. No. 317041, 313321, and 319191) (33). Brains were prepared using the fresh-frozen method. In brief, two female mice (postnatal day 51, P51) and one male mouse (P51) were deeply anesthetized using isoflurane and then rapidly decapitated. Brains were quickly harvested, immediately frozen on dry ice, and kept at −80°C until the day of slicing. After equilibrating the brains at −20°C, 15-μm coronal sections were collected on a cryostat at −20°C and mounted on Superfrost Plus slices (Fisher Scientific, Cat. No. 22037246). Slices were fixed using 10% neutral-buffered formalin (Millipore Sigma, Cat. No. HT501128) and dehydrated in increasing concentrations of ethanol. To block endogenous peroxidase activity, slides were incubated in hydrogen peroxide for 10 min at room temperature followed by application of Protease IV for 30 min. For hybridization, probes targeted to tdTomato, Npy and Vgat, as well as positive and negative controls, were incubated for 2 h at 40°C. After the amplification of the probes, the signal was developed using the horseradish peroxidase (HRP) appropriate for each channel. Opal dyes (1:1,000) were assigned for each channel: Vgat expression was identified by Opal 520 (Akoya Bioscience, Cat. No. FP1487001KT), Npy expression was identified by Opal 570 (Akoya Bioscience, Cat. No. FP1488001KT), and tdTomato expression was identified by Opal 690 (Akoya Bioscience, Cat. No. FP1497001KT). Slices were counterstained with DAPI and coverslipped using ProLong Gold antifade mountant (Fisher Scientific, Cat. No. P36934). Images were acquired within 2 wk of completing the assay. Representative sections (caudal, middle, and rostral, 4 slices per mouse) were imaged at 2-µm depth intervals with a 0.75 NA ×20 objective on a Leica TCS SP8 laser scanning confocal microscope (Leica Microsystems).
To quantify the percentage of colabeling between cells expressing tdTomato, Npy, and Vgat, images were exported to Neurolucida 360 (MBF Bioscience), and quantification was performed manually by placing a marker on the top of each cell expressing the mRNA of interest. Cells in each channel were quantified separately to avoid bias in the analysis. DAPI staining was used to verify whether the mRNA puncta were labeling a cell body.
Immunohistochemistry and Analysis
One male P45 and one female P65 NPY-FlpO × Ai65F mouse were deeply anesthetized in an isoflurane drop jar and then perfused transcardially with PBS for 30–60 s followed by 10% neutral buffered formalin (Millipore Sigma, Cat. No. HT501128) for 10–15 min until ∼100 mL of formalin was perfused. Brains were collected and postfixed for 2 h. Brains were cut into 40-µm sections on a vibrating microtome (VT1200S, Leica Biosystems). Immunofluorescence using an anti-GAD67 antibody was performed as previously described (17, 34, 35). In brief, after being washed in PBS, sections were treated with 10% normal donkey serum (Jackson ImmunoResearch Laboratories, Cat. No. 017-000-121) plus 0.3% Triton X-100 for 2 h. Sections were then incubated in a mouse anti-GAD67 antibody (1:1,000; Millipore Sigma, Cat. No. MAB5406, RRID:AB_2278725) for ∼40 h at 4°C. On the following day, sections were rinsed in PBS and incubated in Alexa Fluor-647-tagged goat anti-mouse IgG (1:100; Thermo Fisher Scientific, Cat. No. A21235, RRID:AB_2535804) for 1.5 h at room temperature. Brain sections were mounted on Superfrost Plus microscope slides (Thermo Fisher Scientific, Cat. No. 12-550-15) and coverslipped using Fluoromount-G (SouthernBiotech, Cat. No. 0100-01). Images were collected using a Leica TCS SP8 laser scanning confocal microscope with a 1.30 NA ×40 oil-immersion objective.
Four coronal IC sections were quantitatively analyzed: two caudal, one mid rostral-caudal, and one rostral. Images of one side of the IC were collected at 2-µm z-stack intervals. Analysis was performed using Neurolucida 360 (MBF Bioscience) by marking the top of each counted cell. Since the anti-GAD67 antibody does not penetrate the entire depth of the tissue sections (34, 35), analysis was restricted to regions in which antibody staining was clear, usually the top 10–12 µm of the surface for each section. Fluorescent channels (tdTomato and Alexa 647) were analyzed separately to limit bias.
Brain Slice Preparation
To characterize the intrinsic physiology of NPY neurons, we performed whole cell patch-clamp electrophysiology experiments in brain slices from male and female mice aged P35–P80. Recordings were targeted to NPY neurons identified in NPY-FlpO × Ai65F (NPYflp) or NPY-hrGFP (NPYgfp) mice by the expression of tdTomato or hrGFP, respectively. Data from the NPY-hrGFP mice were previously shown by Silveira et al. (17). Before decapitation, mice were deeply anesthetized with isoflurane. Dissection of the IC was performed in 34°C artificial cerebrospinal fluid (ACSF) containing the following (in mM): 125 NaCl, 12.5 glucose, 25 NaHCO3, 3 KCl, 1.25 NaH2PO4, 1.5 CaCl2, 1 MgSO4, 3 sodium pyruvate, and 0.40 l-ascorbic acid, bubbled to a pH of 7.4 with 5% CO2 in 95% O2. Coronal brain sections containing the IC (200 µm) were prepared using a vibrating microtome (VT1200S, Leica Biosystems). Slices were incubated at 34°C for 30 min in ACSF bubbled with 5% CO2 in 95% O2 before being transferred to the recording chamber.
Electrophysiological Recordings
Brain slices were maintained at 34°C and continuously perfused at ∼2 mL/min with ACSF bubbled with 5% CO2 in 95% O2. Neurons expressing either hrGFP or tdTomato were identified with epifluorescence using a Nikon FN1 microscope or an Olympus BX51WI microscope. Recordings were performed in current-clamp mode using BVC-700A patch-clamp amplifiers (Dagan Corporation). Data were low-pass filtered at 10 kHz and sampled at 50 kHz with a National Instruments PCIe-6343 data acquisition board. Data acquisition was done using custom software written in Igor Pro (Wavemetrics). Recording pipettes were pulled in a P-1000 microelectrode puller (Sutter Instrument) using borosilicate glass pipettes (outer diameter 1.5 mm, inner diameter 0.86 mm, Cat. No. BF150-86-10, Sutter Instrument). The internal pipette solution contained the following (in mM): 115 K-gluconate, 7.73 KCl, 0.5 EGTA, 10 HEPES, 10 Na2-phosphocreatine, 4 MgATP, 0.3 NaGTP, supplemented with 0.1% biocytin (wt/vol), pH adjusted to 7.3 with KOH and osmolality to 290 mmol/kg with sucrose. Pipette resistance ranged from 2.5 to 5.5 MΩ when filled with the internal solution. To assess input resistance, we delivered a series of 100 ms current steps that hyperpolarized the membrane potential to ∼−100 mV. Peak and steady-state voltage changes were measured, and the peak (Rpk) and steady-state (Rss) input resistances were calculated. To calculate membrane time constant, we applied 40–50, 100–300 ms current steps that hyperpolarized the membrane potential by 2–6 mV. The time constant was obtained by fitting a single exponential function to each response and calculating the median time constant. All membrane potential values were corrected for the liquid junction potential (−11 mV). Pipette capacitance and series resistance were compensated using the bridge balance of the Dagan amplifier. Recordings with series resistance above 20 MΩ were excluded from the analysis.
Post Hoc Reconstructions of Morphology and Analysis
Recorded neurons were filled with biocytin (Thermo Fisher Scientific, Cat. No. B1592) via the recording pipette during whole cell recordings. After the recording, the pipette was slowly removed to allow the cell membrane to reseal. Brain slices were fixed overnight with 10% formalin and were moved to PBS the next day. Slices were stored at 4°C for up to 4 wk, then were stained using biocytin-streptavidin histochemistry. Slices were washed in PBS three times for 10 min each, cell membranes were permeabilized using 0.2% Triton X-100 in PBS for 2 h, washed again 3 × 10 min in PBS, then stained for 24 h with streptavidin-Alexa Fluor-647 (1:1,000, Thermo Fisher Scientific, Cat. No. S21374) at 4°C. The following day, slices were again washed 3 × 10 min with PBS, fixed in 10% formalin for 1 h, and then washed 3 × 10 min with PBS. Slices were then mounted on slides and coverslipped using Fluoromount-G. z-stack tile scan images of streptavidin-Alexa Fluor-647 stained neurons were collected using a 1.4 NA ×63 oil-immersion objective on a Leica TCS SP8 laser scanning confocal microscope.
Images of recorded neurons were imported into Neurolucida 360 software (MBF Bioscience) where three-dimensional (3-D) reconstruction of cell somata and dendritic arbors was performed. The major axes of reconstructed neurons were then measured using procedures we previously developed (17, 35). In brief, neuron reconstructions were first rotated and/or flipped so that the dorsal-ventral axis was vertical, with the dorsal direction at the top, and the lateral-medial axis was horizontal, with the lateral direction to the left. To assess whether NPYflp neurons have a stellate morphology, a 3-D principal component analysis (PCA) was then performed on the x, y, z coordinate set for each neuron. The first and second principal directions from the 3-D PCA were used to determine the length and the width of each NPYflp neuron in three dimensions, and a length-to-width ratio was calculated. To assess the orientation and extent of neurons relative to the plane of the isofrequency laminae, a two-dimensional (2-D) PCA was then performed using the x and y coordinate set for each neuron. The orientation of the first principal component from the 2-D PCA was used to determine the long axis angle of each neuron. The x and y coordinate sets were also used to measure how far the dendrites of each reconstructed neuron extended perpendicular to a 45° laminar plane.
Intracranial Virus Injections
To investigate if NPYflp neurons synapse onto other neurons in the ipsilateral IC, 12 NPY-FlpO mice (5 males and 7 females, aged P25–P82) were injected in the IC with a recombinant adeno-associated virus (rAAV). We tested four different AAVs and did not find any difference between them, therefore the results are reported together. Mice were injected with one of the four viruses: rAAV1/EF1α1.1-FLPX-rc [Chronos-GFP] [Addgene plasmid No. 122102, AAV prepared by University of Michigan Vector Core, titer 8.47 × 1013 VG/ml (36)], rAAV8/nEF-Coff/Fon-ChR2(ET/TC)-EYFP [Addgene No. 137141-AAV8, titer 2.5 × 1013 GC/mL (37)], rAAV5/hSyn Coff/Fon hChR2(H134R)-EYFP [University of North Carolina Vector Core No. 8476, titer 5.8 × 1012 GC/mL (37)], and rAAV8/nEF-ChRmine-oScarlet [Addgene No. 137160-AAV8, titer 2.0 × 1013 GC/mL (38)].
Intracranial injections were performed as previously described (35, 39). After being deeply anesthetized with 3% isoflurane, mice were placed in a stereotaxic base with a homeothermic heating pad. During the surgery, isoflurane was lowered to 1–2% for maintenance. The analgesic Carprofen (5 mg/kg, CarproJect, Henry Schein Animal Health) was administered subcutaneously. The skull was exposed using a rostrocaudal incision, and a craniotomy was made over the left or right IC using a micromotor drill (K.1050, Foredom Electric) with a 0.5 mm burr (Fine Science Tools). The coordinates used for injections (measured relative to lambda) were either 900 µm caudal, 1,000 µm lateral or 900 µm caudal, 1,200 µm lateral. The depth of the injections varied between 1,750 and 2,250 µm (measured relative to skull surface at lambda). Injection pipettes were prepared from glass capillaries (Cat. No. 3-000-203-G/X, Drummond Scientific) pulled with a P-1000 microelectrode puller (Sutter Instrument). The injection tip was front filled with the virus of interest. The scalp was sutured using Ethilon 6-0 (0.7 metric) nylon sutures (Ethicon) or closed using Vetbond Tissue Adhesive (3M). Lidocaine hydrochloride ointment (2%, 0.5 mL, Akorn) was then applied to the wound. Experiments were performed 2–5 wk after injections to allow full expression of the opsins.
Channelrhodopsin-Assisted Circuit Mapping
After preparation of brain slices, recordings were performed under red room lighting to limit the activation of opsins by ambient light. Chronos or Channelrhodopsin were activated by brief pulses of 470 nm light emitted by a blue LED. ChRmine was activated by brief pulses of green light produced by a white LED filtered with a 545 nm bandpass filter with a ±12.5 nm passband (Chroma Technology, Cat. No. ET545/25x). Both LEDs were coupled to the epifluorescence path of the microscope and light was delivered using a 0.80 NA ×40 water immersion objective. Optical power densities ranged from 0.9 to 48 mW/mm2. Light duration ranged from 1 to 3 ms using a 5–30 s intersweep interval. Only sweeps that exhibited a light-evoked inhibitory postsynaptic potential (IPSP) were included in the analysis. In a subset of experiments, we tested for pharmacological block of IPSPs by applying 5 µM gabazine (also called SR95531 hydrobromide, GABAA receptor antagonist, Hello Bio, Cat. No. HB0901) and 1 µM strychnine hydrochloride (glycine receptor antagonist, Millipore Sigma, Cat. No. S8753). Drugs were bath applied for at least 5–10 min before responses were measured.
Statistics
Statistical analyses were performed using R 4.1.0 (The R Project for Statistical Computing), Igor Pro 9 (Wavemetrics), and MATLAB R2021a (MathWorks). For the comparison of the intrinsic physiology between NPYgfp and NPYflp neurons, we used Welch’s t test, and the significance level (α) was adjusted to account for multiple comparisons using Bonferroni correction. For the remaining experiments, effects were considered significant when P < 0.05. Data are shown as means ± SD. PCA was performed using the “coeff” function in MATLAB. The first component of the PCA explained 97.18% of the data. After PCA, a k-means clustering analysis was performed using the “kmeans” function in MATLAB. The “elbow method” was used to determine how many clusters to divide the data into.
RESULTS
Most IC Neurons Labeled in NPY-FlpO × Ai65F Mice Express Npy mRNA and Are GABAergic
To test whether the NPY-FlpO × Ai65F mouse line selectively labels IC neurons that express NPY and are GABAergic, we performed in situ hybridization using an RNAscope assay with probes targeted to mRNAs encoding tdTomato, Npy, and the vesicular GABA transporter, Vgat. Two females and one male NPY-FlpO × Ai65F mouse, all aged P51, were used for the assay. We found that 75.6% (3,111 of 4,115) of tdTomato+ neurons expressed Npy, and 92.9% (3,822 of 4,115) of tdTomato+ neurons expressed Vgat (Fig. 1, A–E, Table 1). A small percentage of neurons expressing Npy did not express tdTomato (4.6%, 191 of 4,115). To confirm the neurotransmitter content of NPYflp neurons, we also performed immunofluorescence against GAD67, an enzyme essential for GABA synthesis and an established marker of GABAergic IC neurons (17, 34, 35, 40, 41). Using representative coronal IC sections from one male (P45) mouse and one female (P65) mouse, we found that 92.2% (2,333 of 2,528) of tdTomato+ neurons were labeled with anti-GAD67 (Fig. 1, F–H; Table 2). The NPY-FlpO × Ai65F mouse line therefore predominately labels a population of GABAergic neurons, three-quarters of which expressed Npy at the time of the assay.
Figure 1.
Most tdTomato+ neurons in NPY-FlpO × Ai65F mice express Npy and are GABAergic. A–E: fluorescent in situ hybridization (RNAscope) was used to determine the expression patterns of tdTomato, Npy, and Vgat mRNA in the inferior colliculus (IC) of NPY-FlpO × Ai65F mice. A: low-magnification coronal IC section from an NPY-FlpO × Ai65F mouse shows the distribution of tdTomato+ (magenta), Npy+ (yellow), and Vgat+ (cyan) neurons in the IC. B–E: high-magnification confocal images show that tdTomato+ neurons (B, magenta) typically colabeled with Npy (C, yellow) and Vgat probes (D, cyan). Merged image shown in E. White arrows highlight examples of neurons that colabeled. Scale bar in E applies to images in B–E. F–H: immunofluorescence shows that 92.3% of tdTomato+ neurons are GABAergic. High-magnification confocal images show tdTomato+ neurons (F, magenta) immunolabeled with antibodies against the GABA synthetic enzyme, GAD67 (G, cyan). Merge in H. Scale bar in H applies to images in F–H.
Table 1.
Nearly all tdTomato+ neurons expressed Vgat and three-quarters expressed Npy
| Mouse | tdTomato+ | tdTomato+ Npy+ | % tdTomato+ Npy+/tdTomato+ | tdTomato+ Vgat+ | % tdTomato+ Vgat+/ tdTomato+ | Npy+ | % tdTomato+ Npy+/ Npy+ |
|---|---|---|---|---|---|---|---|
| Female P51 | 154 | 108 | 70.1 | 127 | 82.5 | 117 | 92.3 |
| 609 | 464 | 76.2 | 580 | 95.2 | 482 | 96.3 | |
| 420 | 290 | 69.0 | 414 | 98.6 | 298 | 97.3 | |
| 271 | 205 | 75.6 | 257 | 94.8 | 230 | 89.1 | |
| Female P51 | 498 | 389 | 78.1 | 464 | 93.2 | 398 | 97.7 |
| 394 | 317 | 80.5 | 364 | 92.4 | 326 | 97.2 | |
| 338 | 290 | 85.8 | 305 | 90.2 | 299 | 97.0 | |
| 465 | 340 | 73.1 | 413 | 88.8 | 348 | 97.7 | |
| Male P51 | 345 | 280 | 81.2 | 329 | 95.4 | 298 | 94.0 |
| 157 | 93 | 59.2 | 133 | 84.7 | 123 | 75.6 | |
| 132 | 80 | 60.6 | 127 | 96.2 | 117 | 68.4 | |
| 332 | 255 | 76.8 | 309 | 93.1 | 266 | 95.9 | |
| Total | 4,115 | 3,111 | 75.60 | 3,822 | 92.9 | 3,302 | 94.22 |
Table 2.
Nearly all tdTomato+ neurons colabeled with GAD67
| Mouse | tdTomato+ | tdTomato+ GAD67+ | tdTomato+ GAD67− | % tdTomato+ GAD67+/ tdTomato+ |
|---|---|---|---|---|
| Male P45 | 456 | 423 | 8 | 92.8 |
| 745 | 661 | 49 | 88.7 | |
| Female P65 | 380 | 337 | 32 | 88.7 |
| 947 | 912 | 14 | 96.3 | |
| Total | 2,528 | 2,333 | 103 | 92.3 |
To test whether the NPY-FlpO × Ai65F mouse line reliably labels the population of neurons expressing Npy at the time of assay (as opposed to a subset), we next analyzed the in situ hybridization data for colabeling of Npy+ cells. The results showed that 94.2% of Npy+ cells expressed tdTomato and 99.4% expressed Vgat (Table 3). Thus, the NPY-FlpO × Ai65F mouse line labels nearly all Npy-expressing cells, and, as we found in our previous study (17), Npy-expressing cells are GABAergic.
Table 3.
Over half of Vgat+ neurons expressed tdTomato and/or Npy
| Mouse | Vgat+ | Vgat+ Npy+ | % Vgat+ Npy+/Vgat+ | Vgat+ tdTomato+ | % Vgat+ tdTomato+/Vgat+ | Npy+ | % Vgat+ Npy+/Npy+ |
|---|---|---|---|---|---|---|---|
| Female P51 | 321 | 117 | 36.4 | 127 | 39.6 | 117 | 100.0 |
| 822 | 482 | 58.6 | 580 | 70.6 | 482 | 100.0 | |
| 707 | 297 | 42.0 | 414 | 58.6 | 298 | 99.7 | |
| 451 | 228 | 50.6 | 257 | 57.0 | 230 | 99.1 | |
| Female P51 | 594 | 398 | 67.0 | 464 | 78.1 | 398 | 100.0 |
| 499 | 326 | 65.3 | 364 | 72.9 | 326 | 100.0 | |
| 473 | 298 | 63.0 | 305 | 64.5 | 299 | 99.7 | |
| 500 | 346 | 69.2 | 413 | 82.6 | 348 | 99.4 | |
| Male P51 | 493 | 297 | 60.2 | 329 | 66.7 | 298 | 99.7 |
| 322 | 115 | 35.7 | 133 | 41.3 | 123 | 93.5 | |
| 442 | 115 | 26.0 | 127 | 28.7 | 117 | 98.3 | |
| 409 | 262 | 64.1 | 309 | 75.6 | 266 | 98.5 | |
| Total | 6,033 | 3,281 | 54.38 | 3,822 | 63.35 | 3,302 | 99.36 |
Together, these results indicate that the NPY-FlpO × Ai65F mouse line drove tdTomato expression in three populations of neurons under our experimental conditions: 75.1% were GABAergic neurons that expressed Npy at the time of assay, 17.8% were GABAergic neurons that did not express Npy at the time of assay, and 7.1% were non-GABAergic (presumptive glutamatergic) neurons that did not express Npy at the time of the assay (calculations based on the assumption that 99.4% of tdTomato+ Npy+ neurons were GABAergic). This differs from our previous study in which we used an antibody against NPY to label sections from NPY-hrGFP mice. Using that approach, we found that 94.7% of NPYgfp neurons expressed NPY (17). This suggests that the lineage-tracking approach of the NPY-FlpO × Ai65F mouse line results in broader labeling than the expression-tracking approach of the NPY-hrGFP mouse line. The broader labeling in the NPY-FlpO × Ai65F mouse line could be due to ectopic expression of tdTomato in non-NPY-expressing neurons, labeling of neurons that expressed NPY at some point prior to the date of assay but not on the assay day, or some combination of the two. Importantly, we examined IC sections from two Ai65F mice and did not observe any tdTomato expression in the IC (data not shown). It is therefore unlikely that tdTomato expression in non-NPY-expressing neurons in NPY-FlpO × Ai65F mice could be explained by leaky expression from the Flp-dependent tdTomato transgene. Since NPY can be expressed transiently during development and can be regulated by extrinsic factors (24, 25), we hypothesize that most of the additional labeling in the NPY-FlpO × Ai65F mouse line was due to labeling neurons that fit the NPY class definition (i.e., GABAergic neurons with sustained firing patterns and stellate morphology) but were not actively expressing Npy at the time of assay.
NPYflp and NPYgfp Neurons Have Similar Distributions but Different Densities in the IC
To analyze the distribution and density of labeled cells in each mouse line, we examined fluorescently labeled NPY cells in the IC of both NPY-hrGFP and NPY-FlpO × Ai65F mice. Figure 2A shows low-magnification images of the IC in NPY-hrGFP (green, left) or NPY-FlpO × Ai65F (magenta, right) mice. In both types of mice, fluorescently labeled cells are readily visible throughout the IC, including in each major IC subdivision and through the caudo-rostral extent of the nucleus. Commissural fibers are fluorescently labeled in each type of mouse (arrows), indicating the participation of NPY cells in the IC commissural pathway. In a major difference between the two types of mice, GABA modules of the lateral cortex of the IC (IClc) (42) are visible in the NPY-FlpO × Ai65F mouse IC (arrowheads) but not visible in the NPY-hrGFP mouse IC. A second difference between the two types of mice is the increased density of fluorescent cells in the NPY-FlpO × Ai65F mouse IC. This increased density was also visible at higher magnification (Fig. 2B). The density of fluorescent cells was increased in the NPY-FlpO × Ai65F mouse IC as compared with the NPY-hrGFP mouse IC in each major subdivision of the IC. This was especially visible in the IClc (Fig. 2B, bottom row), where clusters of NPYflp cells were present within GABA modules. As at lower magnifications, IC commissural fibers are readily visible in the dorsal cortex of the IC (ICd) of each type of mouse (Fig. 2B, middle row), although fibers appeared brighter (compared to somatic fluorescence) and denser in the NPY-hrGFP mouse IC.
Figure 2.
NPYflp and NPYgfp neurons have similar distributions but different densities in the inferior colliculus (IC). A: low-magnification photomicrographs showing NPYgfp (left column, green) or NPYflp (right column, magenta) fluorescence in the IC. For each type of mouse, sections from the caudal (top row), mid (middle row), or rostral (bottom row) IC are shown. Note that commissural fibers can be seen in both types of mice (arrows), while GABA modules from the IClc (arrowheads) are only visible in NPY-FlpO × Ai65F mice. Scale = 500 µm. B: high-magnification photomicrographs showing NPYgfp (left column, green) or NPYflp (right column, magenta) fluorescence in each IC subdivision. Fluorescent cells (denoted with asterisks) are readily visible in each subdivision in both types of mice (top row: ICc, middle row: ICd, bottom row: IClc). However, cells were more numerous in a given field in each subdivision in NPY-FlpO × Ai65F mice. Note especially the presence of many NPYflp cells in a GABA module in the IClc. Fluorescent axons and boutons are also readily visible in each subdivision in both types of mice, and commissural axons are especially prominent in the ICd of both types of mice. Scale = 20 µm. C: plots showing each fluorescent cell in four representative sections in one case from each type of mouse. One green circle denotes one NPYgfp cell and one magenta circle denotes one NPYflp cell. For both cases, sections are arranged from caudal (left) to rostral (right). D, dorsal; M, medial. D and E: bar graphs showing the percentage of total population in each subdivision (D) and density of cells per mm2 in each subdivision and overall (E) for NPYgfp cells (green bars) and NPYflp cells (magenta). Bars show means ± SD. n = 24,609 NPYgfp cells across nine NPY-hrGFP mice and 33,911 NPYflp cells across three NPY-FlpO × Ai65F mice. IC, inferior colliculus; ICc, central nucleus of the IC; ICd, dorsal cortex of the IC; IClc, lateral cortex of the IC; NPYflp, neuropeptide Y neurons labeled through a lineage-tracing approach; NPYgfp, neuropeptide Y neurons labeled through an expression-tracking approach.
To further investigate the difference in density of fluorescent cells between the two models, we plotted each fluorescently labeled cell through the IC in nine NPY-hrGFP mice and three NPY-FlpO × Ai65F mice. Representative sections from each model are shown in Fig. 2C, where each circle represents one fluorescent cell. We found no difference in the relative distribution of labeled cells between the IC subdivisions when we compared the percentage of the total population present in each subdivision (Fig. 2D). However, when we compared the density of fluorescent cells (cells per mm2 of subdivision area), we found a much higher density of NPYflp as compared with NPYgfp neurons in the IC (Fig. 2E). This combination of higher density and similar distribution seems to indicate no major differences in the cell populations that are fluorescently labeled in the two types of mice, however subtle differences do seem to exist (e.g., clusters of NPYflp cells in IClc modules that are not labeled in the NPY-hrGFP mouse IC).
The Intrinsic Physiology of NPYflp Neurons Is Similar to NPYgfp Neurons
Neurons in the IC exhibit heterogeneous intrinsic physiological properties (43). Previously, we showed that NPYgfp neurons exhibit a sustained firing pattern, low expression of hyperpolarization-activated cation current (Ih), and moderate input resistances and membrane time constants (17). Because our in situ hybridization results suggested that the NPY-FlpO × Ai65F mouse labels a larger population of neurons than the NPY-hrGFP mouse line, we hypothesized that the intrinsic physiology of this larger population remains homogeneous compared with the NPYgfp neurons. To test this hypothesis, we performed whole cell current clamp recordings targeted to NPYflp neurons and compared their intrinsic physiology with our previous data for NPYgfp neurons. The firing pattern of each neuron was classified based on the spike frequency adaptation ratio (SFA) in response to a depolarizing current step, such that neurons with an SFA > 2 were classified as adapting and neurons with an SFA < 2 were classified as sustained (43). We found that 85% of NPYflp neurons exhibited a sustained firing pattern (n = 50/59), similar to the 95% we saw previously for NPYgfp neurons (n = 123/129; Fig. 3, A and B). The mean SFA ratios for NPYflp neurons trended higher than those of NPYgfp neurons (NPYflp neurons = 1.73 ± 0.78; NPYgfp neurons = 1.26 ± 0.66; means ± SD), but this difference was not statistically significant (SFA ratio for current steps eliciting 5 spikes comparing NPYflp vs. NPYgfp neurons: Welch’s t test, P = 0.056. Since six physiological parameters were compared for the same cells for the experiment shown in Fig. 3, the Bonferroni-corrected α = 0.008).
Figure 3.
NPYflp and NPYgfp neurons exhibit similar intrinsic physiological properties. A: NPYflp (magenta) and NPYgfp (green) neurons exhibited sustained firing patterns. B–G: NPYflp and NPYgfp neurons exhibited similar spike frequency adaptation ratios (B), membrane time constants (C), voltage-dependent sag ratios (D), resting membrane potentials (E), input resistances measured from the peaks of a series of hyperpolarizing responses (F), and input resistances measured from the steady state portions of a series of hyperpolarizing responses (G). P values from Welch’s t tests are shown atop each plot. ISI, interspike interval; NPYflp, neuropeptide Y neurons labeled through a lineage-tracing approach; NPYgfp, neuropeptide Y neurons labeled through an expression-tracking approach; Rm, membrane resistance; RMP, resting membrane potential; Rpk, peak input resistance; Rss, steady-state input resistance; τmembrane, membrane time constant; Vrest, membrane potential at rest.
To calculate the membrane time constant, negative current steps were used to hyperpolarize the membrane potential 2–6 mV, and 40–50 sweeps were recorded. An exponential function was fit to each sweep and the median τ was obtained. The membrane time constant of NPYflp neurons was similar to that of NPYgfp neurons (13.1 ± 6.9 ms vs. 15.9 ± 8.5 ms; Welch’s t test, P = 0.018. Bonferroni-corrected α = 0.008, Fig. 3C). When injected with a hyperpolarizing current step, NPYflp and NPYgfp neurons exhibited moderate sag ratios suggesting relatively low expression of Ih (0.85 ± 0.10 vs. 0.89 ± 0.09; Welch’s t test, P = 0.014; Bonferroni-corrected α = 0.0083, Fig. 3D). The resting membrane potential was slightly more hyperpolarized for NPYflp neurons compared with NPYgfp neurons (−65.8 ± 5.1 mV vs. −63.5 ± 3.8 mV; Welch’s t test, P = 0.004; Bonferroni-corrected α = 0.008), but the effect size was small (mean difference of 2.8 mV, Fig. 3E). Finally, input resistance measured at the peak (Rpk) or at the steady state of the hyperpolarizing response (Rss) was similar between NPYflp and NPYgfp neurons (Rpk: 216.9 ± 100.8 MΩ vs. 237.8 ± 120.1 MΩ; Welch’s t test, P = 0.055; Bonferroni-corrected α = 0.008, Fig. 3F, Rss: 209.6 ± 129.0 MΩ vs. 252.7 ± 167.6 MΩ; Welch’s t test, P = 0.2186; Bonferroni-corrected α = 0.008, Fig. 3G).
Next, we performed PCA to test whether NPYflp and NPYgfp neurons have overlapping or separable distributions based on intrinsic physiology. PCA analysis was conducted by combining the NPYflp and NPYgfp data sets for the six intrinsic physiology parameters assessed previously: SFA ratio, membrane time constant, voltage sag ratio, resting membrane potential, Rpk, and Rss. The results from the PCA analysis suggested that NPYflp and NPYgfp neurons have largely overlapping distributions (Fig. 4A). We next performed k-means cluster analysis that was set to identify two clusters (the optimal number of clusters defined by the “elbow method,” see Fig. 4B, inset). We found that 86.4% of NPYflp neurons and 71.3% of NPYgfp neurons were part of cluster 1 whereas the remaining neurons fell into cluster 2, suggesting that the two populations of NPY neurons were similarly divided between the two clusters (Fig. 4B). We then compared the intrinsic physiology of cells in cluster 1 to cells in cluster 2 (Fig. 4, C–H). Cells in cluster 1 had faster membrane time constants (11.9 ± 5.5 ms vs. 24.8 ± 7.4 ms; Welch’s t test, P = 1.651 × 10−15; Bonferroni-corrected α = 0.008, Fig. 4D), higher expression of Ih (sag ratio: 0.85 ± 0.09 vs. 0.96 ± 0.04; Welch’s t test, P = 5.272 × 10−19; Bonferroni-corrected α = 0.008, Fig. 4D), and lower input resistance (Rpk: 179.2 ± 59.8 MΩ vs. 396.3 ± 86.9 MΩ; Welch’s t test, P = 2.155 × 10−22; Bonferroni-corrected α = 0.008, Fig. 4G; Rss: 165.4 ± 67.4 MΩ vs. 473.3 ± 129.9 MΩ; Welch’s t test, P = 8.820 × 10−21; Bonferroni-corrected α = 0.008, Fig. 4H). Spike frequency adaptation ratio and resting membrane potential were not significantly different between the clusters (SFA: 1.42 ± 1.2 vs. 1.37 ± 0.5; Welch’s t test, P = 0.704; Bonferroni-corrected α = 0.008, Fig. 4C; resting membrane potential (RMP): −63.9 ± 4.3 mV vs. −65.1 ± 4.3 mV; Welch’s t test, P = 0.112; Bonferroni-corrected α = 0.008, Fig. 4F). We therefore conclude that the k-means cluster analysis separated faster cells with higher expression of Ih from slower cells with lower expression of Ih. Interestingly, a higher percentage of NPYgfp neurons was present in cluster 2 than NPYflp neurons (28.7% vs. 13.6%), suggesting that NPYflp neurons did not have more diversity in physiological properties than NPYgfp neurons, despite the likely inclusion in the NPYflp group of a subset of neurons not expressing NPY at the time of experiment. Thus, it is unlikely that NPY expression correlates with a change in intrinsic physiology. Overall, the presence of NPYflp and NPYgfp in both clusters 1 and 2 supports the hypothesis that both neuron groups originate from the same class of neurons.
Figure 4.
Principal component analysis does not differentiate between NPYflp and NPYgfp neurons. A: principal component analysis (PCA) showed that the distributions of NPYflp (magenta) and NPYgfp (green) neurons largely overlapped. B: k-means cluster analysis identified two clusters of neurons from the PCA results, represented by yellow and blue dots (dot positions are identical to A). Both clusters contained NPYflp and NPYgfp neurons, with cluster 1 (yellow) containing 86.4% of NPYflp neurons and 71.3% of NPYgfp neurons, showing that NPYflp and NPYgfp neurons were not separable based on their intrinsic physiology. The number of clusters used for analysis was defined using the “elbow” analysis method, which showed that the addition of a third cluster did little to improve the separation between cluster centroids (inset graph). C–F: comparisons of the intrinsic physiological properties of cluster 1 (yellow) and cluster 2 (blue) neurons: spike frequency adaptation ratios (C); membrane time constants (D); voltage-dependent sag ratios (E); and resting membrane potentials (F). G and H: input resistances measured from the peaks of a series of hyperpolarizing responses (G) and from the steady-state portions of a series of hyperpolarizing responses (H). P values from Welch’s t tests are shown atop each plot. ISI, interspike interval; NPYflp, neuropeptide Y neurons labeled through a lineage-tracing approach; NPYgfp, neuropeptide Y neurons labeled through an expression-tracking approach; Rm, membrane resistance; RMP, resting membrane potential; Rpk, peak input resistance; Rss, steady-state input resistance; τmembrane, membrane time constant; Vrest, membrane potential at rest.
NPYflp Neurons Have Stellate Morphology Similar to NPYgfp Neurons
We reconstructed the morphology of 15 recorded NPYflp neurons using biocytin-streptavidin staining. Figure 5A shows all reconstructed neurons, all of which were located in the central nucleus of the IC (ICc). For comparison purposes, all neurons were oriented as they would appear in the left side of a coronal IC slice viewed from the caudal side.
Figure 5.
A: representative reconstructions of the morphology of 15 NPYflp neurons that were filled with biocytin during recordings from the ICc. Gray lines represent the approximate orientation and width of ICc isofrequency lamina (∼45° angle and 100 µm, respectively). B: three-dimensional (3-D) principal component analysis (PCA) analysis was performed to classify neuron morphology using the ratio of the longest and second-longest axes of each neuron (i.e., length and width), with a ratio <3 indicating stellate morphology. C: angular orientation of the long axis of reconstructed neurons. As illustrated in the inset, angles indicate counterclockwise rotation of the long axis relative to the medial-lateral (horizontal) axis of the IC such that a 45° angle is parallel to the isofrequency plane. D: length dendritic arbors of NPYflp neurons extended perpendicular to the isofrequency laminae plane. NPYflp, neuropeptide Y neurons labeled through a lineage-tracing approach.
First, using an approach developed in our earlier studies (17, 35), we used 3-D PCA to classify the morphology of each neuron as stellate or disk-shaped. This analysis was done on the x, y, z coordinate set for each NPYflp neuron to determine the extent along the first principal direction (length) and extent along the second principal direction (width) of each neuron in three dimensions. We then calculated the length-to-width ratio of the dendritic arbor of each neuron. Previous work has shown that stellate neurons have a length-to-width ratio <3 and disk-shaped neurons have a ratio of ≥3 (30). We found that all reconstructed neurons had a length-to-width ratio <3, consistent with the hypothesis that NPYflp neurons are stellate shaped (Fig. 5B).
In the mouse ICc, isofrequency laminae extend at a ∼45° angle relative to the horizontal plane, and disk-shaped neurons are expected to have a long axis that extends parallel to the isofrequency laminae (44, 45). As in our previous studies (17, 35), we used 2-D PCA to calculate the orientation of the long axis of NPYflp neuron dendritic arbors in the coronal plane in relation to ICc isofrequency laminae. The results show that reconstructed NPYflp neurons did not have a preferred orientation, and only one neuron had an orientation that was parallel to the isofrequency laminae (Fig. 5C).
Because the dendrites of ICc neurons typically extend across more than one isofrequency lamina, we measured the distance ICc NPYflp neurons extended their dendrites perpendicular to a 45° laminar plane. We found that only one of 15 NPYflp neurons had a dendritic arbor that extended <90 µm perpendicular to the laminar plane and only two of 15 had dendritic arbors that extended <150 µm perpendicular to the laminar plane (Fig. 5D). This suggests that most NPYflp neurons have dendrites that extend across two or more isofrequency lamina, with some branching across more than five laminae.
NPYflp Neurons Form Local Inhibitory Circuits in the IC
Most neurons in the IC are thought to project to extrinsic targets and to also have local axon collaterals, allowing them to contribute to local circuits (30, 46). We recently showed that neurons that express the NPY Y1 receptor form interconnected excitatory networks in the local IC (39). However, whether NPY neurons contribute to local IC circuits is still unknown. In addition, while our anatomical data indicate that NPY neurons are GABAergic [Fig. 1 and Silveira et al. (17)], the neurotransmitter content of NPY neurons has not been assessed functionally. Because most techniques for manipulating distinct neuron types are optimized to target neurons that express Cre and/or FlpO transgenes (37, 38, 47), the NPY-hrGFP mouse line is not amenable for selectively manipulating NPY neurons. By contrast, to test if NPYflp neurons form functional connections within local IC circuits, we were able to use FlpO-dependent adeno-associates viruses (AAVs) to selectively express excitatory channelrhodopsins in NPY-FlpO mice (see methods for details).
Although NPYflp neurons are distributed throughout the IC, our data showed that most neurons expressing excitatory opsins (Chronos-GFP, ChR2-EYFP, ChR2-mCherry, or ChRmine-mScarlet) following Flp-dependent AAV transfections were restricted to the edge of the IC (Fig. 6A). This result suggests that despite strong expression of NPY in the IC, the FlpO expression in the IC is likely to be low in this mouse line. To test whether channelrhodopsins drive firing in NPY neurons, we first targeted recordings to cells expressing the fluorophore. We found that presentation of light elicited action potential trains (Fig. 6B). We next targeted recordings to other neurons near the transfected area and found that 1–5 ms pulses of blue light elicited inhibitory postsynaptic potentials (IPSPs) in 13 of 28 cells recorded (peak amplitude = −2.0 ± 1.3 mV, mean ± SD, Fig. 6, C and D). In a subset of neurons (n = 6), we subsequently applied gabazine (5 µM) and strychnine (1 µM) to block GABAA and glycine receptors. In all cases, the light-evoked IPSP was abolished in the presence of these drugs (amplitude in control condition: −1.8 mV ± 0.9 mV; amplitude in gabazine + strychnine: 0 mV; Welch’s t test, P = 0.0005, Fig. 6, E and F). These data indicate that NPYflp neurons contribute to local circuits in the IC by providing functional inhibitory input to other IC neurons.
Figure 6.

NPYflp neurons provide inhibitory input to IC neurons in the ipsilateral inferior colliculus (IC). A: confocal image showing the typical expression pattern observed when using a FlpO-dependent channelrhodopsin virus to transfect IC neurons in an NPY-FlpO mouse. This example shows transfection with adeno-associated virus (AAV)1/EF1α1.1-FLPX-rc [Chronos-GFP]. B: representative example of a whole-cell recording targeted to a GFP+ cell from a mouse injected in the IC with a FlpO-dependent Chronos-GFP virus (AAV1/EF1α1.1-FLPX-rc [Chronos-GFP]). Presentation of a blue light pulse elicited action potentials, confirming the ability to use optogenetics to drive NPY neuron firing. Black trace highlights a representative trial, and gray traces show additional individual trials. C: representative example of optogenetically evoked inhibitory postsynaptic potentials (IPSPs) elicited by activating NPYflp neurons and/or terminals in the local IC. Brief flashes of blue light could be used to elicit single IPSPs or trains of IPSPs (20 Hz light presentation shown). D: distribution of IPSP amplitudes observed across all recorded cells that received input from NPYflp neurons. E: representative example trace of optogenetically evoked IPSPs recorded from a neuron that received input from an NPYflp neuron (left). The response was abolished with application of GABAA and glycine receptor antagonists (right). F: application of gabazine (5 µM) and strychnine (1 µM) abolished light-evoked IPSPs in all cells. In C and E, gray traces represent individual trials and black traces represent averages across trials. NPYflp, neuropeptide Y neurons labeled through a lineage-tracing approach.
DISCUSSION
Here, we compared lineage-tracing and expression-tracking approaches for identifying NPY neurons in the IC. We found that the lineage-tracing, NPY-FlpO × Ai65F mouse line labels an expanded set of neurons in the IC compared with the expression-tracking, NPY-hrGFP mouse line. Although the percentages of neurons expressing Npy mRNA or peptide differed between mouse lines (75.6% NPYflp vs. 94.7% NPYgfp), the neurotransmitter content, anatomical distribution, and morphological and physiological features of fluorophore-labeled neurons remained similar between mouse lines. Our data therefore suggest that neurons actively expressing NPY and neurons that previously expressed NPY belong to the same class of neurons. Since NPY expression can be regulated by extrinsic factors, we propose that NPY neurons in the IC comprise both neurons actively expressing NPY and neurons with the potential to express NPY.
In addition, using targeted optogenetics, we found that NPY neurons provide inhibitory input to other neurons in the ipsilateral IC, expanding the repertoire of postsynaptic targets for NPY neurons beyond the commissural and tectothalamic projections previously shown (17, 48). Thus, we conclude that NPY neurons represent a larger than previously known class of inhibitory IC neurons that contribute to local and long-range inhibitory circuits and in which NPY expression might be dynamically regulated.
Lineage-Tracing Reveals a Larger Population of NPY Neurons in the IC
Across brain regions, it is well established that different classes of neurons play different roles in neuronal computations (49–51). Understanding the organization and function of neuronal circuits therefore requires the ability to identify and manipulate distinct neuron types. Although the IC is a major site of auditory processing, it was not until recently that molecularly identifiable neuron types have been identified in the IC (17, 34, 35, 52). Among those neuron types, NPY neurons were the first molecularly identifiable class of GABAergic neurons (here called NPYgfp neurons) (17). Here, we show that a lineage-tracing approach reveals a larger population of neurons that fit the NPY class definition than the expression-tracking approach used in our previous study. These results could be interpreted in two ways. First, they could indicate that NPY is transiently expressed during development in a subset of IC neurons and that these neurons are not able to express NPY in adulthood. If this interpretation is correct, NPYflp neurons would likely be divided into two different classes of neurons: one consistent with the NPYgfp neurons previously described and another representing a previously unknown neuron type. However, our data challenge this hypothesis as NPYflp neurons had anatomical, morphological, and physiological features similar to NPYgfp neurons. Although our morphological analyses showed that all the NPYflp neurons we reconstructed had stellate morphology, a few neurons had distinctly smaller dendrites than others. This could be a result of the dendritic arbors of these neurons being cut when sliced for experiments, but it could also indicate heterogeneity within the NPY neuron population. Consistent with this, the Allen Brain Cell Atlas identifies 44 clusters of GABAergic neurons in the IC, 15 of which express NPY (53). In addition, it is important to note that our examination of NPY expression was performed using different approaches across mouse lines. For the NPY-hrGFP mouse line, we used an antibody against NPY (17), and here we used fluorescent in situ hybridization to label neurons expressing Npy mRNA in NPY-FlpO × Ai65F mice. Although mRNA expression does not always reflect peptide expression, we found that 94.2% of neurons expressing Npy mRNA also expressed tdTomato mRNA in IC sections from NPY-FlpO × Ai65F. This was remarkably similar to the 94.7% of hrGFP-positive neurons that labeled with an anti-NPY antibody in IC sections from NPY-hrGFP mice (17) and suggests that immunofluorescence and fluorescent in situ hybridization work similarly well for tracking NPY expression in the IC.
Second, differences in the number of labeled NPY neurons could suggest that NPY expression in the IC is dynamic and influenced by extrinsic factors. Dynamic changes in NPY expression have been described in other brain regions. For example, in the hypothalamus, Npy expression changes with food restriction (13, 20, 21) and, in the hippocampus and frontal cortex, NPY release is enhanced during seizures (54–57). In the auditory brainstem, the number of lateral olivocochlear efferent neurons expressing NPY increased after noise exposure (23). Similarly, NPY expression in the IC might increase during and/or following periods of heightened activity, which might be caused by noisy environments, audiogenic seizures, and other stimuli. In addition, the IC exhibits enhanced central gain after hearing loss (58, 59), and therefore noise trauma might also induce changes in NPY expression. Since NPY signaling dampens the excitability of most glutamatergic IC neurons (17, 39), increased NPY expression following hearing loss might help keep enhanced central gain from driving hyperexcitability in the IC. In future studies, we hope to investigate whether NPY expression changes across different stages of development and/or in response to extrinsic factors such as noise exposure.
These findings also raise the importance of carefully planning experiments when using Cre/Flp/Dre recombinase-driver mouse lines. For example, in the dorsal horn, the role of NPY neurons was initially underestimated because viral approaches used to selectively target NPY neurons transfected neurons that transiently expressed NPY during development as well as neurons that expressed NPY in adulthood (60). It was not until recently, using a viral strategy to transfect only neurons that expressed NPY during adulthood, that it was recognized that dorsal horn NPY neurons have a broader role in pain and itch (16). Similarly, for future studies using the NPY-FlpO mouse line to label NPY neurons in the IC, it will be important to consider the developmental stage when Flp-dependent virus transfections are performed and possibly also the environmental conditions in which mice are housed (e.g., ambient noise levels).
Finally, we note that 7.1% of tdTomato-expressing neurons in the NPY-FlpO × Ai65F mouse line were negative for Vgat mRNA expression. There are several possible explanations for this. First, there may be some leakage of FlpO expression in the NPY-FlpO mouse such that some non-NPY neurons express FlpO. Second, NPY might be transiently expressed during development in a small population of non-GABAergic IC neurons. Third, the anti-Vgat probe used in the RNAscope assay might not have labeled all Vgat-expressing cells. Although these are important considerations to keep in mind, in the realm of recombinase-driver mouse lines, where expression patterns are rarely perfect, the ∼93% efficacy of the NPY-FlpO × Ai65F mouse line in labeling GABAergic IC neurons and our observation that NPYflp and NPYgfp neurons had highly similar properties suggest that the NPY-FlpO mouse is a useful tool for studying IC NPY neurons.
Considerations for Using FlpO-Driver Mouse Lines
Despite the large number of neurons expressing Npy in NPY-FlpO × Ai65F mice (∼75% of tdTomato+ neurons expressed Npy mRNA), the Flp-dependent viral transfections we conducted produced fluorescence in relatively few neurons, and this fluorescence was more prevalent in the shell regions of the IC. This pattern was observed with all four viruses tested suggesting that it was not dependent on the virus serotype, viral promoter, or the excitatory opsin being expressed (see methods for list of viruses tested). This result suggests that FlpO expression in P25–P82 mice (the age range when virus injections were conducted) is stronger in IC shell regions than in the ICc in the NPY-FlpO mouse line. The difference between tdTomato expression driven by the mouse cross and opsin expression driven by virus transfection might be explained by the fact that there is more time for recombination to take place in the mouse cross and recombination only has to take place once in the genome of each cell or in one of its parent cells. However, with viral transfections, recombination must take place within the ∼3–4 wk between virus injection and the experiment date, and to get strong expression, recombination must take place multiple times per cell to allow expression from each or most of the viruses that transfect a cell. The expression pattern we observed with virus transfection could be useful for future studies focused on local inhibitory circuits in the shell IC. However, we cannot rule out the possibility that NPYflp neurons in the ICc also expressed excitatory opsins but at lower levels than were detectable on our electrophysiology rig microscope.
On the other hand, a recent study provided evidence that FlpO has poorer recombinase activity than Cre, which may explain the relatively poor expression of Flp-dependent viral constructs we observed in NPY-FlpO mice (61). Although this may be a disadvantage for experiments aiming to uniformly label NPY neurons using viral transfections, it may create an opportunity for experiments aiming to tie reporter gene expression levels to driver gene expression levels (61). For example, since manipulations that enhance NPY expression should also enhance FlpO expression in NPY-FlpO mice, the expression of Flp-dependent viral constructs might change following noise exposure, audiogenic seizures, hearing loss, or other manipulations that might alter NPY expression. It will be interesting to see whether this feature of FlpO can be leveraged in future studies.
NPY Neurons Contribute to Local IC Circuits
The IC is rich in local circuits and most IC neurons are thought to have local axon collaterals (30, 62–64). Using glutamate uncaging, previous studies showed that IC GABAergic neurons contribute to local IC circuits, and the distribution of intrinsic inhibitory connections changed with development and noise exposure (65, 66). We previously showed that at least a portion of NPY neurons are principal neurons that project to the auditory thalamus and/or the contralateral IC (17, 48), but functional evidence that NPY neurons provide inhibitory input was lacking. Here, using channelrhodopsin-assisted circuit mapping, we found that NPY neurons provide inhibitory synaptic input to other neurons in the local IC. This suggests that NPY neurons are indeed GABAergic and that activation of NPY neurons elicits an inhibitory postsynaptic potential in the postsynaptic target. Importantly, this is the first evidence of a molecularly identifiable class of GABAergic neurons providing inputs to other neurons in the local IC. Despite previous anatomical evidence suggesting that most IC neurons have local axon collaterals (30, 62, 63), the only other studies that functionally evaluated local inhibitory projections did so at earlier developmental stages and without identifying the classes of inhibitory neurons mediating responses (64–66). In future studies, we hope to address whether other GABAergic neurons also contribute to local IC circuits and whether individual NPY neurons project to multiple targets or if subsets of NPY neurons project to different targets.
In the IC, synaptic inhibition influences frequency tuning and direction selectivity for frequency modulated (FM) sweeps, both of which are important for processing speech and other vocalizations (67, 68). In addition, diminished synaptic inhibition in the IC is a common feature in aging and age-related hearing loss (69, 70). Since NPY neurons represent a large proportion of IC GABAergic neurons (17), inhibitory inputs from NPY neurons may be well positioned to shape frequency tuning, FM direction selectivity, and other auditory computations. NPY neurons might also use the corelease of GABA and NPY to regulate local circuits over spatial and temporal scales that are not possible with GABA release alone. For example, we showed that ∼80% of IC glutamatergic neurons express the NPY Y1 receptor, and these neurons are hyperpolarized by exogenous application of NPY (39). Therefore, NPY release is expected to dampen the excitability of most glutamatergic neurons in the IC, potentially improving the precision of auditory computations and acting as a brake on hyperexcitability.
Together, our data show that NPY neurons in the IC encompass a larger population of IC GABAergic neurons than previously reported, that NPY expression might be developmentally and/or dynamically regulated in these neurons, and that NPY neurons contribute to local inhibitory circuits in the IC. Future studies should focus on determining what drives NPY expression in IC neurons.
DATA AVAILABILITY
Data will be made available upon reasonable request.
GRANTS
This work was supported by National Institutes of Health Grants R01 DC018284 (to M.T.R.), K99 DC019415 (to M.A.S.), F31 DC021618 (to Y.N.H.), T32 DC000011 (to Y.N.H.), and the University Hospitals Hearing Research Center at NEOMED.
DISCLOSURES
No conflicts of interest, financial or otherwise, are declared by the authors.
AUTHOR CONTRIBUTIONS
M.A.S. and M.T.R. conceived and designed research; M.A.S., Y.N.H., N.L.B., and B.R.S. performed experiments; M.A.S., Y.N.H., N.L.B., B.R.S., and M.T.R. analyzed data; M.A.S., Y.N.H., N.L.B., B.R.S., and M.T.R. interpreted results of experiments; M.A.S., Y.N.H., and N.L.B. prepared figures; M.A.S. and Y.N.H. drafted manuscript; M.A.S., Y.N.H., N.L.B., B.R.S., and M.T.R. edited and revised manuscript; M.A.S., Y.N.H., N.L.B., B.R.S., and M.T.R. approved final version of manuscript.
ACKNOWLEDGMENTS
Preprint is available at https://doi.org/10.1101/2024.03.27.587042.
REFERENCES
- 1. van den Pol AN. Neuropeptide transmission in brain circuits. Neuron 76: 98–115, 2012. doi: 10.1016/j.neuron.2012.09.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Urban-Ciecko J, Barth AL. Somatostatin-expressing neurons in cortical networks. Nat Rev Neurosci 17: 401–409, 2016. doi: 10.1038/nrn.2016.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Guillaumin MCC, Burdakov D. Neuropeptides as primary mediators of brain circuit connectivity. Front Neurosci 15: 644313, 2021. doi: 10.3389/fnins.2021.644313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Colmers WF, Bleakman D. Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci 17: 373–379, 1994. doi: 10.1016/0166-2236(94)90046-9. [DOI] [PubMed] [Google Scholar]
- 5. Sun Q-Q, Baraban SC, Prince DA, Huguenard JR. Target-specific neuropeptide Y-ergic synaptic inhibition and its network consequences within the mammalian thalamus. J Neurosci 23: 9639–9649, 2003. doi: 10.1523/JNEUROSCI.23-29-09639.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Fu L-Y, Acuna-Goycolea C, van den Pol AN. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci 24: 8741–8751, 2004. doi: 10.1523/JNEUROSCI.2268-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Nusbaum MP, Blitz DM, Marder E. Functional consequences of neuropeptide and small-molecule co-transmission. Nat Rev Neurosci 18: 389–403, 2017. doi: 10.1038/nrn.2017.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Nässel DR. Neuropeptide signaling near and far: how localized and timed is the action of neuropeptides in brain circuits? Invert Neurosci 9: 57–75, 2009. doi: 10.1007/s10158-009-0090-1. [DOI] [PubMed] [Google Scholar]
- 9. Woldbye DP, Madsen TM, Larsen PJ, Mikkelsen JD, Bolwig TG. Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res 737: 162–168, 1996. doi: 10.1016/0006-8993(96)00730-5. [DOI] [PubMed] [Google Scholar]
- 10. Gøtzsche CR, Woldbye DPD. The role of NPY in learning and memory. Neuropeptides 55: 79–89, 2016. doi: 10.1016/j.npep.2015.09.010. [DOI] [PubMed] [Google Scholar]
- 11. Britton KT, Southerland S, Van Uden E, Kirby D, Rivier J, Koob G. Anxiolytic activity of NPY receptor agonists in the conflict test. Psychopharmacology (Berl) 132: 6–13, 1997. doi: 10.1007/s002130050313. [DOI] [PubMed] [Google Scholar]
- 12. Gutman AR, Yang Y, Ressler KJ, Davis M. The role of neuropeptide Y in the expression and extinction of fear-potentiated startle. J Neurosci 28: 12682–12690, 2008. doi: 10.1523/JNEUROSCI.2305-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Pedroso JAB, Silveira MA, Lima LB, Furigo IC, Zampieri TT, Ramos-Lobo AM, Buonfiglio DC, Teixeira PDS, Frazão R, Donato J Jr.. Changes in leptin signaling by SOCS3 modulate fasting-induced hyperphagia and weight regain in mice. Endocrinology 157: 3901–3914, 2016. doi: 10.1210/en.2016-1038. [DOI] [PubMed] [Google Scholar]
- 14. Reichmann F, Holzer P. Neuropeptide Y: a stressful review. Neuropeptides 55: 99–109, 2016. doi: 10.1016/j.npep.2015.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Li Q, Bartley AF, Dobrunz LE. Endogenously released neuropeptide Y suppresses hippocampal short-term facilitation and is impaired by stress-induced anxiety. J Neurosci 37: 23–37, 2017. doi: 10.1523/JNEUROSCI.2599-16.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Boyle KA, Polgar E, Gutierrez-Mecinas M, Dickie AC, Cooper AH, Bell AM, Jumolea E, Casas-Benito A, Watanabe M, Hughes DI, Weir GA, Riddell JS, Todd AJ. Neuropeptide Y-expressing dorsal horn inhibitory interneurons gate spinal pain and itch signalling. eLife 12: RP86633, 2023. doi: 10.7554/eLife.86633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Silveira MA, Anair JD, Beebe NL, Mirjalili P, Schofield BR, Roberts MT. Neuropeptide Y expression defines a novel class of GABAergic projection neuron in the inferior colliculus. J Neurosci 40: 4685–4699, 2020. doi: 10.1523/JNEUROSCI.0420-20.2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Polgár E, Sardella TC, Watanabe M, Todd AJ. Quantitative study of NPY-expressing GABAergic neurons and axons in rat spinal dorsal horn. J Comp Neurol 519: 1007–1023, 2011. doi: 10.1002/cne.22570. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Karagiannis A, Gallopin T, Dávid C, Battaglia D, Geoffroy H, Rossier J, Hillman EMC, Staiger JF, Cauli B. Classification of NPY-expressing neocortical interneurons. J Neurosci 29: 3642–3659, 2009. doi: 10.1523/JNEUROSCI.0058-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Brady LS, Smith MA, Gold PW, Herkenham M. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 52: 441–447, 1990. doi: 10.1159/000125626. [DOI] [PubMed] [Google Scholar]
- 21. Li C, Chen P, Smith MS. The acute suckling stimulus induces expression of neuropeptide Y (NPY) in cells in the dorsomedial hypothalamus and increases NPY expression in the arcuate nucleus. Endocrinology 139: 1645–1652, 1998. doi: 10.1210/endo.139.4.5905. [DOI] [PubMed] [Google Scholar]
- 22. Wu Q, Lemus MB, Stark R, Bayliss JA, Reichenbach A, Lockie SH, Andrews ZB. The temporal pattern of cfos activation in hypothalamic, cortical, and brainstem nuclei in response to fasting and refeeding in male mice. Endocrinology 155: 840–853, 2014. doi: 10.1210/en.2013-1831. [DOI] [PubMed] [Google Scholar]
- 23. Frank MM, Sitko AA, Suthakar K, Torres Cadenas L, Hunt M, Yuk MC, Weisz CJC, Goodrich LV. Experience-dependent flexibility in a molecularly diverse central-to-peripheral auditory feedback system. eLife 12: e83855, 2023. doi: 10.7554/eLife.83855. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Botchkina GI, Lyubsky S, Hagag NG. Transient expression of neuropeptide Y (NPY) immunoreactivity in the developing hamster paraventricular thalamic area is due to apoptosis. Cell Mol Neurobiol 16: 649–659, 1996. doi: 10.1007/BF02151902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Morara S, Marcotti W, Provini L, Rosina A. Neuropeptide Y (NPY) expression is up-regulated in the rat inferior olive during development. Neuroreport 8: 3743–3747, 1997. doi: 10.1097/00001756-199712010-00017. [DOI] [PubMed] [Google Scholar]
- 26. Grove KL, Brogan RS, Smith MS. Novel expression of neuropeptide Y (NPY) mRNA in hypothalamic regions during development: region-specific effects of maternal deprivation on NPY and Agouti-related protein mRNA. Endocrinology 142: 4771–4776, 2001. doi: 10.1210/endo.142.11.8498. [DOI] [PubMed] [Google Scholar]
- 27. Litovsky RY, Fligor BJ, Tramo MJ. Functional role of the human inferior colliculus in binaural hearing. Hear Res 165: 177–188, 2002. doi: 10.1016/s0378-5955(02)00304-0. [DOI] [PubMed] [Google Scholar]
- 28. Carney LH, Li T, McDonough JM. Speech coding in the brain: representation of vowel formants by midbrain neurons tuned to sound fluctuations. eNeuro 2: ENEURO.0004-15, 2015, 2015. doi: 10.1523/ENEURO.0004-15.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Keine C, Rübsamen R, Englitz B. Inhibition in the auditory brainstem enhances signal representation and regulates gain in complex acoustic environments. eLife 5: e19295, 2016. doi: 10.7554/eLife.19295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Oliver DL, Kuwada S, Yin TC, Haberly LB, Henkel CK. Dendritic and axonal morphology of HRP-injected neurons in the inferior colliculus of the cat. J Comp Neurol 303: 75–100, 1991. doi: 10.1002/cne.903030108. [DOI] [PubMed] [Google Scholar]
- 31. van den Pol AN, Yao Y, Fu L-Y, Foo K, Huang H, Coppari R, Lowell B, Broberger C. Neuromedin B and gastrin releasing peptide excite arcuate nucleus neuropeptide Y neurons in a novel transgenic mouse expressing strong renilla GFP in NPY neurons. J Neurosci 29: 4622–4639, 2009. doi: 10.1523/JNEUROSCI.3249-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Daigle TL, Madisen L, Hage TA, Valley MT, Knoblich U, Larsen RS, , et al. A suite of transgenic driver and reporter mouse lines with enhanced brain-cell-type targeting and functionality. Cell 174: 465–480.e22, 2018. doi: 10.1016/j.cell.2018.06.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Wang F, Flanagan J, Su N, Wang L-C, Bui S, Nielson A, Wu X, Vo H-T, Ma X-J, Luo Y. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn 14: 22–29, 2012. doi: 10.1016/j.jmoldx.2011.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Beebe NL, Young JW, Mellott JG, Schofield BR. Extracellular molecular markers and soma size of inhibitory neurons: evidence for four subtypes of GABAergic cells in the inferior colliculus. J Neurosci 36: 3988–3999, 2016. doi: 10.1523/JNEUROSCI.0217-16.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Goyer D, Silveira MA, George AP, Beebe NL, Edelbrock RM, Malinski PT, Schofield BR, Roberts MT. A novel class of inferior colliculus principal neurons labeled in vasoactive intestinal peptide-Cre mice. eLife 8: e43770, 2019. doi: 10.7554/eLife.43770. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Klapoetke NC, Murata Y, Kim SS, Pulver SR, Birdsey-Benson A, Cho YK, Morimoto TK, Chuong AS, Carpenter EJ, Tian Z, Wang J, Xie Y, Yan Z, Zhang Y, Chow BY, Surek B, Melkonian M, Jayaraman V, Constantine-Paton M, Wong GK-S, Boyden ES. Independent optical excitation of distinct neural populations. Nat Methods 11: 338–346, 2014. [Erratum in Nat Methods 11: 971, 2014]. doi: 10.1038/nmeth.2836. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Fenno LE, Mattis J, Ramakrishnan C, Hyun M, Lee SY, He M, Tucciarone J, Selimbeyoglu A, Berndt A, Grosenick L, Zalocusky KA, Bernstein H, Swanson H, Perry C, Diester I, Boyce FM, Bass CE, Neve R, Huang ZJ, Deisseroth K. Targeting cells with single vectors using multiple-feature Boolean logic. Nat Methods 11: 763–772, 2014. doi: 10.1038/nmeth.2996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Fenno LE, Ramakrishnan C, Kim YS, Evans KE, Lo M, Vesuna S, Inoue M, Cheung KYM, Yuen E, Pichamoorthy N, Hong ASO, Deisseroth K. Comprehensive dual- and triple-feature intersectional single-vector delivery of diverse functional payloads to cells of behaving mammals. Neuron 107: 836–853.e11, 2020. doi: 10.1016/j.neuron.2020.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Silveira MA, Drotos AC, Pirrone TM, Versalle TS, Bock A, Roberts MT. Neuropeptide Y signaling regulates recurrent excitation in the auditory midbrain. J Neurosci 43: 7626–7641, 2023. doi: 10.1523/JNEUROSCI.0900-23.2023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Ono M, Yanagawa Y, Koyano K. GABAergic neurons in inferior colliculus of the GAD67-GFP knock-in mouse: Electrophysiological and morphological properties. Neurosci Res 51: 475–492, 2005. doi: 10.1016/j.neures.2004.12.019. [DOI] [PubMed] [Google Scholar]
- 41. Ito T, Bishop DC, Oliver DL. Two classes of GABAergic neurons in the inferior colliculus. J Neurosci 29: 13860–13869, 2009. doi: 10.1523/JNEUROSCI.3454-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Chernock ML, Larue DT, Winer JA. A periodic network of neurochemical modules in the inferior colliculus. Hear Res 188: 12–20, 2004. doi: 10.1016/S0378-5955(03)00340-X. [DOI] [PubMed] [Google Scholar]
- 43. Peruzzi D, Sivaramakrishnan S, Oliver DL. Identification of cell types in brain slices of the inferior colliculus. Neuroscience 101: 403–416, 2000. doi: 10.1016/s0306-4522(00)00382-1. [DOI] [PubMed] [Google Scholar]
- 44. Morest DK, Oliver DL. The neuronal architecture of the inferior colliculus in the cat: defining the functional anatomy of the auditory midbrain. J Comp Neurol 222: 209–236, 1984. doi: 10.1002/cne.902220206. [DOI] [PubMed] [Google Scholar]
- 45. Stiebler I, Ehret G. Inferior colliculus of the house mouse. I. A quantitative study of tonotopic organization, frequency representation, and tone-threshold distribution. J Comp Neurol 238: 65–76, 1985. doi: 10.1002/cne.902380106. [DOI] [PubMed] [Google Scholar]
- 46. Ito T, Bishop DC, Oliver DL. Functional organization of the local circuit in the inferior colliculus. Anat Sci Int 91: 22–34, 2016. doi: 10.1007/s12565-015-0308-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Fenno L, Yizhar O, Deisseroth K. The development and application of optogenetics. Annu Rev Neurosci 34: 389–412, 2011. doi: 10.1146/annurev-neuro-061010-113817. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Anair JD, Silveira MA, Mirjalili P, Beebe NL, Schofield BR, Roberts MT. Inhibitory NPY neurons provide a large and heterotopic commissural projection in the inferior colliculus. Front Neural Circuits 16: 871924, 2022. doi: 10.3389/fncir.2022.871924. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Ascoli GA, Alonso-Nanclares L, Anderson SA, Barrionuevo G, Benavides-Piccione R, Burkhalter A, , et al. Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat Rev Neurosci 9: 557–568, 2008. doi: 10.1038/nrn2402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Pelkey KA, Chittajallu R, Craig MT, Tricoire L, Wester JC, McBain CJ. Hippocampal GABAergic inhibitory interneurons. Physiol Rev 97: 1619–1747, 2017. doi: 10.1152/physrev.00007.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Zeng H, Sanes JR. Neuronal cell-type classification: challenges, opportunities and the path forward. Nat Rev Neurosci 18: 530–546, 2017. doi: 10.1038/nrn.2017.85. [DOI] [PubMed] [Google Scholar]
- 52. Kreeger LJ, Connelly CJ, Mehta P, Zemelman BV, Golding NL. Excitatory cholecystokinin neurons of the midbrain integrate diverse temporal responses and drive auditory thalamic subdomains. Proc Natl Acad Sci USA 118: e2007724118, 2021. doi: 10.1073/pnas.2007724118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Yao Z, van Velthoven CTJ, Kunst M, Zhang M, McMillen D, Lee C, , et al. A high-resolution transcriptomic and spatial atlas of cell types in the whole mouse brain. Nature 624: 317–332, 2023. doi: 10.1038/s41586-023-06812-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Marksteiner J, Sperk G. Concomitant increase of somatostatin, neuropeptide Y and glutamate decarboxylase in the frontal cortex of rats with decreased seizure threshold. Neuroscience 26: 379–385, 1988. doi: 10.1016/0306-4522(88)90155-8. [DOI] [PubMed] [Google Scholar]
- 55. Marksteiner J, Sperk G, Maas D. Differential increases in brain levels of neuropeptide Y and vasoactive intestinal polypeptide after kainic acid-induced seizures in the rat. Naunyn Schmiedebergs Arch Pharmacol 339: 173–177, 1989. doi: 10.1007/BF00165140. [DOI] [PubMed] [Google Scholar]
- 56. Gruber B, Greber S, Rupp E, Sperk G. Differential NPY mRNA expression in granule cells and interneurons of the rat dentate gyrus after kainic acid injection. Hippocampus 4: 474–482, 1994. doi: 10.1002/hipo.450040409. [DOI] [PubMed] [Google Scholar]
- 57. Noe' F, Nissinen J, Pitkänen A, Gobbi M, Sperk G, During M, Vezzani A. Gene therapy in epilepsy: the focus on NPY. Peptides 28: 377–383, 2007. doi: 10.1016/j.peptides.2006.07.025. [DOI] [PubMed] [Google Scholar]
- 58. Chambers AR, Resnik J, Yuan Y, Whitton JP, Edge AS, Liberman MC, Polley DB. Central gain restores auditory processing following near-complete cochlear denervation. Neuron 89: 867–879, 2016. doi: 10.1016/j.neuron.2015.12.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Shaheen LA, Liberman MC. Cochlear synaptopathy changes sound-evoked activity without changing spontaneous discharge in the mouse inferior colliculus. Front Syst Neurosci 12: 59, 2018. doi: 10.3389/fnsys.2018.00059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Bourane S, Duan B, Koch SC, Dalet A, Britz O, Garcia-Campmany L, Kim E, Cheng L, Ghosh A, Ma Q, Goulding M. Gate control of mechanical itch by a subpopulation of spinal cord interneurons. Science 350: 550–554, 2015. doi: 10.1126/science.aac8653. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Zhao C, Ries C, Du Y, Zhang J, Sakimura K, Itoi K, Deussing JM. Differential CRH expression level determines efficiency of Cre- and Flp-dependent recombination. Front Neurosci 17: 1163462, 2023. doi: 10.3389/fnins.2023.1163462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Saldaña E, Merchán M. Intrinsic and commissural connections of the inferior colliculus. In: The Inferior Colliculus, edited by Winer JA, Schreiner CE. New York: Springer, 2005, p.155–181. [Google Scholar]
- 63. Chen C, Cheng M, Ito T, Song S. Neuronal organization in the inferior colliculus revisited with cell-type-dependent monosynaptic tracing. J Neurosci 38: 3318–3332, 2018. doi: 10.1523/JNEUROSCI.2173-17.2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Chandrasekaran L, Xiao Y, Sivaramakrishnan S. Functional architecture of the inferior colliculus revealed with voltage-sensitive dyes. Front Neural Circuits 7: 41, 2013. doi: 10.3389/fncir.2013.00041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Sturm J, Nguyen T, Kandler K. Development of intrinsic connectivity in the central nucleus of the mouse inferior colliculus. J Neurosci 34: 15032–15046, 2014. [Erratum in J Neurosci 35: 6978, 2015]. doi: 10.1523/JNEUROSCI.2276-14.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Sturm JJ, Zhang-Hooks Y-X, Roos H, Nguyen T, Kandler K. Noise trauma-induced behavioral gap detection deficits correlate with reorganization of excitatory and inhibitory local circuits in the inferior colliculus and are prevented by acoustic enrichment. J Neurosci 37: 6314–6330, 2017. doi: 10.1523/JNEUROSCI.0602-17.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Kuo RI, Wu GK. The generation of direction selectivity in the auditory system. Neuron 73: 1016–1027, 2012. doi: 10.1016/j.neuron.2011.11.035. [DOI] [PubMed] [Google Scholar]
- 68. Pollak GD. The dominant role of inhibition in creating response selectivities for communication calls in the brainstem auditory system. Hear Res 305: 86–101, 2013. doi: 10.1016/j.heares.2013.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Caspary DM, Milbrandt JC, Helfert RH. Central auditory aging: GABA changes in the inferior colliculus. Exp Gerontol 30: 349–360, 1995. doi: 10.1016/0531-5565(94)00052-5. [DOI] [PubMed] [Google Scholar]
- 70. Ibrahim BA, Llano DA. Aging and central auditory disinhibition: is it a reflection of homeostatic downregulation or metabolic vulnerability? Brain Sci 9: 351, 2019. doi: 10.3390/brainsci9120351. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data will be made available upon reasonable request.





